TP73 and gastric cancer: In addition, in terms of drug resistance, Peng et al. found that the overexpression of TP73-AS1 is associated with enhanced drug resistance in GC cells, and reducing the expression of TP73-AS1 can enhance the sensitivity of GC cells to the chemotherapeutic drug cisplatin [35].